XTX Topco Ltd Increases Stock Position in Chemed Co. (NYSE:CHE)

XTX Topco Ltd lifted its stake in Chemed Co. (NYSE:CHE) by 51.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,344 shares of the company’s stock after acquiring an additional 458 shares during the period. XTX Topco Ltd’s holdings in Chemed were worth $729,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CHE. Norges Bank purchased a new position in Chemed during the 4th quarter valued at about $92,359,000. TD Asset Management Inc grew its stake in Chemed by 164.3% during the fourth quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock valued at $120,328,000 after acquiring an additional 127,934 shares in the last quarter. Epoch Investment Partners Inc. increased its holdings in Chemed by 85.2% during the 4th quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company’s stock worth $88,977,000 after acquiring an additional 70,001 shares during the period. Impax Asset Management Group plc lifted its stake in Chemed by 19.5% in the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after purchasing an additional 51,974 shares in the last quarter. Finally, ProShare Advisors LLC boosted its holdings in Chemed by 6,288.9% in the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock valued at $32,482,000 after purchasing an additional 49,808 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Chemed news, Director George J. Walsh III sold 200 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the transaction, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares of the company’s stock, valued at $3,478,159.15. The disclosure for this sale can be found here. Insiders sold a total of 6,744 shares of company stock valued at $3,828,231 in the last quarter. Corporate insiders own 3.32% of the company’s stock.

Chemed Price Performance

CHE opened at $582.06 on Monday. Chemed Co. has a one year low of $497.36 and a one year high of $654.62. The firm has a market capitalization of $8.81 billion, a P/E ratio of 31.33, a price-to-earnings-growth ratio of 2.31 and a beta of 0.44. The company has a fifty day moving average price of $569.34 and a 200-day moving average price of $577.23.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same quarter in the prior year, the company earned $4.71 earnings per share. Chemed’s revenue was up 7.6% compared to the same quarter last year. On average, analysts expect that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed’s payout ratio is presently 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.